Thalidomide-Piperazine-Piperidine hydrochloride structure
|
Common Name | Thalidomide-Piperazine-Piperidine hydrochloride | ||
---|---|---|---|---|
CAS Number | 2599846-44-1 | Molecular Weight | 461.94 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C22H28ClN5O4 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Thalidomide-Piperazine-Piperidine hydrochlorideThalidomide-Piperazine-Piperidine hydrochloride is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-Piperazine-Piperidine hydrochloride incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
Name | Thalidomide-Piperazine-Piperidine hydrochloride |
---|
Description | Thalidomide-Piperazine-Piperidine hydrochloride is a synthesized E3 ligase ligand-linker conjugate. Thalidomide-Piperazine-Piperidine hydrochloride incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1]. |
---|---|
Related Catalog | |
Target |
Cereblon |
In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. |
References |
Molecular Formula | C22H28ClN5O4 |
---|---|
Molecular Weight | 461.94 |
Hazard Codes | Xi |
---|